OptimizeRx Corp
OPRX· Nasdaq
OPRXOptimizeRx Corp
Filed Mar 12, 2013 · 10-K · 71 days after period end · 0001255294-13-000182
derived · Computed from the longer spans the company filed.
| Metric | Q4 2012dderived from reported figures | Q4 2011dderived from reported figures | Q4 2010dderived from reported figures |
|---|---|---|---|
| Revenue | $691.11K | $325.91K | — |
| Net Income | $28.42K | -$93.14K | -$368.58K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
OptimizeRx Corp · CIK 1448431 · Engraved from SEC EDGAR
ended Dec 31, 2012 · filed Mar 12, 2013 · 71 d after period end
